DSIP

Safety Considerations

Non-sedating, non-habit forming Rare side effects: vivid dreams, headache, mild grogginess Avoid in patients with epilepsy or severe psychiatric disorders Not FDA-approved for human use; for clinical use under provider oversight only

Molecule / Formula

C35H48N10O15

DSIP 10mg/5mL DOSING

  • 10 units low dose

  • 15 units moderate dose

  • 20-25 units typical dose

    Start low, acclimate, titrate up based on how you feel

What Is the DSIP

Delta Sleep-Inducing Peptide(DSIP) is a naturally occurring neuropeptide first isolated in the 1970s for its potent sleep promoting properties. Unlike conventional sedatives, DSIP works by gently modulating the sleep cycle especially promoting delta wave (deep) sleep without suppressing REM or causing next-day grogginess.

How It Works

DSIP operates through several key pathways:

  • Sleep Regulation: Enhances slow-wave (delta) sleep and promotes sleep onset without acting as a direct sedative.

  • Hypothalamic Modulation: Balances hormonal rhythms, potentially aiding in stress reduction and circadian alignment.

  • Neuroprotective Effects: DSIP has demonstrated antioxidant properties and may reduce excitotoxicity in the central nervous system.

  • Cortisol & Stress Modulation: Helps normalize stress-related hormonal patterns, making it useful in individuals with sleep disturbances linked to HPA axis dysregulation.

  • Promotes delta wave (slow-wave) sleep without suppressing REM

  • Modulates CRF (corticotropin-releasing factor) to reduce cortisol Regulates circadian rhythms and melatonin secretion

  • Interacts with NMDA and GAB receptors to reduce excitotoxicity

  • Shows antioxidant and neuroprotective activity in CNS models

Benefit

  • Enhances deep, restorative sleep

  • Reduces stress-related sleep disturbances

  • Supports hormonal balance and circadian regulation

  • May improve mental clarity, mood, and daytime energy via better sleep quality

  • Non-sedative option for sleep support protocols